ATE272717T1 - Verfahren zum screening von antibakteriellen mitteln - Google Patents
Verfahren zum screening von antibakteriellen mittelnInfo
- Publication number
- ATE272717T1 ATE272717T1 AT99954191T AT99954191T ATE272717T1 AT E272717 T1 ATE272717 T1 AT E272717T1 AT 99954191 T AT99954191 T AT 99954191T AT 99954191 T AT99954191 T AT 99954191T AT E272717 T1 ATE272717 T1 AT E272717T1
- Authority
- AT
- Austria
- Prior art keywords
- antibacterial agents
- subpopulation
- identified
- bacteria
- stationary phase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10765598P | 1998-11-09 | 1998-11-09 | |
GBGB9824553.3A GB9824553D0 (en) | 1998-11-09 | 1998-11-09 | Improvements in or relating to screening antibacterial agents |
GBGB9909962.4A GB9909962D0 (en) | 1999-04-29 | 1999-04-29 | Improvemments in or relating to screening antibacterial agents |
PCT/GB1999/003728 WO2000028074A1 (en) | 1998-11-09 | 1999-11-09 | Screening process for antibacterial agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE272717T1 true ATE272717T1 (de) | 2004-08-15 |
Family
ID=27269546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99954191T ATE272717T1 (de) | 1998-11-09 | 1999-11-09 | Verfahren zum screening von antibakteriellen mitteln |
Country Status (10)
Country | Link |
---|---|
US (3) | US20020031819A1 (de) |
EP (1) | EP1129212B1 (de) |
JP (1) | JP3737365B2 (de) |
AT (1) | ATE272717T1 (de) |
AU (1) | AU1061100A (de) |
DE (1) | DE69919196T2 (de) |
DK (1) | DK1129212T3 (de) |
ES (1) | ES2229780T3 (de) |
PT (1) | PT1129212E (de) |
WO (1) | WO2000028074A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6982153B1 (en) * | 1998-12-03 | 2006-01-03 | Targanta Therapeutics, Inc. | DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides |
GB0522715D0 (en) | 2005-11-08 | 2005-12-14 | Helperby Therapeutics Ltd | New use |
US20080220465A1 (en) * | 2007-03-05 | 2008-09-11 | Pocared Diagnostics, Inc. | Antibiotic Sensitivity Testing Method |
WO2011121345A1 (en) | 2010-03-30 | 2011-10-06 | Helperby Therapeutics Limited | Novel combination and use |
WO2011160048A2 (en) * | 2010-06-17 | 2011-12-22 | The Johns Hopkins University | Methods of identifying therapeutic agents for treating persister and bacterial infection |
US8940723B2 (en) | 2010-08-05 | 2015-01-27 | Helperby Therapeutics Limited | Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine |
GB201013207D0 (en) | 2010-08-05 | 2010-09-22 | Helperby Therapeutics Ltd | Novel combination |
GB201015079D0 (en) | 2010-09-10 | 2010-10-27 | Helperby Therapeutics Ltd | Novel use |
GB201305277D0 (en) | 2013-03-22 | 2013-05-01 | Helperby Therapeutics Ltd | Novel combination and use |
GB201307989D0 (en) | 2013-05-02 | 2013-06-12 | Helperby Therapeutics Ltd | Novel combinations and use |
GB201401617D0 (en) | 2014-01-30 | 2014-03-19 | Helperby Therapeutics Ltd | Novel combination and use |
US10335454B2 (en) | 2014-12-18 | 2019-07-02 | Helperby Therapeutics Limited | Combination and use |
JP6804096B2 (ja) | 2015-04-11 | 2020-12-23 | ヘルパービー セラピューティクス リミテッドHelperby Therapeutics Limited | 口腔用組成物 |
GB201518969D0 (en) | 2015-10-27 | 2015-12-09 | Helperby Therapeutics Ltd | Triple combination |
GB201521771D0 (en) | 2015-12-10 | 2016-01-27 | Helperby Therapeutics Ltd | Formulation |
GB201610869D0 (en) | 2016-06-22 | 2016-08-03 | Helperby Therapeutics Ltd | Combination |
GB201612093D0 (en) | 2016-07-12 | 2016-08-24 | Helperby Therapeutics Ltd | Combination |
GB201616014D0 (en) | 2016-09-20 | 2016-11-02 | Helperby Therapeutics Ltd | Combination |
GB201616909D0 (en) | 2016-10-05 | 2016-11-16 | Helperby Therapeutics Ltd | Combination |
GB201703898D0 (en) | 2017-03-10 | 2017-04-26 | Helperby Therapeautics Ltd | Method |
GB201704620D0 (en) | 2017-03-23 | 2017-05-10 | Helperby Therapeautics Ltd | Combinations |
GB201709193D0 (en) | 2017-06-09 | 2017-07-26 | Helperby Therapeutics Ltd | Combination |
GB201807046D0 (en) | 2018-04-30 | 2018-06-13 | Helperby Therapeutics Ltd | Combination |
GB2589286A (en) * | 2019-07-22 | 2021-06-02 | Helperby Therapeutics Ltd | Method |
GB201913068D0 (en) | 2019-09-10 | 2019-10-23 | Helperby Therapeutics Ltd | Combination |
GB201914847D0 (en) | 2019-10-14 | 2019-11-27 | Helperby Therapeutics Ltd | Combination |
GB202213753D0 (en) | 2022-09-20 | 2022-11-02 | Helperby Therapeutics Ltd | Antimicrobial combinations |
GB202213750D0 (en) | 2022-09-20 | 2022-11-02 | Helperby Therapeutics Ltd | Antimicrobial |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3697648A (en) * | 1968-05-24 | 1972-10-10 | Meiji Seika Ltd Kk | Antibiotic sf-767-a and sf767-l substances,and process for producing same culturing a certain streptomyces microsporeus |
US3963576A (en) | 1975-02-21 | 1976-06-15 | General Environmental Science Corporation | Method for rendering bacteria dormant and the product produced thereby |
US4234579A (en) * | 1977-06-07 | 1980-11-18 | Pfizer Inc. | Penicillanic acid 1,1-dioxides as β-lactamase inhibitors |
US5670350A (en) * | 1990-08-20 | 1997-09-23 | Novartis Finance Corporation | Genomic DNA encoding a pseudomonas global transcriptional activation element and its use in activating gene expression |
US5684144A (en) * | 1993-07-28 | 1997-11-04 | University Of North Texas | Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof |
US5712095A (en) * | 1994-06-16 | 1998-01-27 | Becton Dickinson And Company | Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probes specific for ribosomal RNA precursors |
US5733774A (en) * | 1995-02-02 | 1998-03-31 | Ecoscience Corporation | Method and composition for producing stable bacteria and bacterial formulations |
US5700925A (en) * | 1996-03-27 | 1997-12-23 | The Johns Hopkins University | DNA encoding stationary phase, stress response sigma factor from Mycobacterium tuberculosis |
US6890526B2 (en) * | 1997-05-06 | 2005-05-10 | Vanderbilt University | Methods and reagents for the treatment of multiple sclerosis |
US5963576A (en) * | 1997-08-04 | 1999-10-05 | Motorola, Inc. | Annular waveguide vertical cavity surface emitting laser and method of fabrication |
-
1999
- 1999-11-09 DK DK99954191T patent/DK1129212T3/da active
- 1999-11-09 PT PT99954191T patent/PT1129212E/pt unknown
- 1999-11-09 AT AT99954191T patent/ATE272717T1/de active
- 1999-11-09 DE DE69919196T patent/DE69919196T2/de not_active Expired - Lifetime
- 1999-11-09 JP JP2000581240A patent/JP3737365B2/ja not_active Expired - Fee Related
- 1999-11-09 AU AU10611/00A patent/AU1061100A/en not_active Abandoned
- 1999-11-09 ES ES99954191T patent/ES2229780T3/es not_active Expired - Lifetime
- 1999-11-09 EP EP99954191A patent/EP1129212B1/de not_active Expired - Lifetime
- 1999-11-09 WO PCT/GB1999/003728 patent/WO2000028074A1/en active IP Right Grant
-
2001
- 2001-04-27 US US09/842,637 patent/US20020031819A1/en not_active Abandoned
-
2004
- 2004-08-17 US US10/919,354 patent/US20050019892A1/en not_active Abandoned
-
2008
- 2008-12-23 US US12/343,176 patent/US7892782B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU1061100A (en) | 2000-05-29 |
US7892782B2 (en) | 2011-02-22 |
DE69919196D1 (de) | 2004-09-09 |
ES2229780T3 (es) | 2005-04-16 |
US20050019892A1 (en) | 2005-01-27 |
EP1129212B1 (de) | 2004-08-04 |
DE69919196T2 (de) | 2005-08-04 |
US20020031819A1 (en) | 2002-03-14 |
JP2002529103A (ja) | 2002-09-10 |
DK1129212T3 (da) | 2004-11-22 |
WO2000028074A1 (en) | 2000-05-18 |
EP1129212A1 (de) | 2001-09-05 |
US20090104651A1 (en) | 2009-04-23 |
JP3737365B2 (ja) | 2006-01-18 |
PT1129212E (pt) | 2004-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE272717T1 (de) | Verfahren zum screening von antibakteriellen mitteln | |
EP0885958A4 (de) | Methode zur behandlung von biopolymeren, mikroorganismen oder anderen materialien, die mehr als einen typ von magnetischen partikeln benutzt. | |
BR9810151A (pt) | Composto, composição farmacêutica e método para tratamento ou prevenção de uma desordem tromoboembólica | |
DE69519747D1 (de) | Enzymatisches verfahren zum nachweis coliformer bakterien oder e.coli | |
ATE271555T1 (de) | Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren | |
DE60041770D1 (de) | Bifidobacteria zum vorbeugen von diarrhöe infolge pathogener bakterien | |
DE69722771D1 (de) | Verfahren zum nachweis der enzymaktivität von mikroorganismen | |
DE60129556D1 (de) | Verfahren zur fleisch verarbeitung und zum bearbeiten von informationen | |
DE59201253D1 (de) | Verfahren zum, insbesondere beschleunigten, aeroben mikrobiologischen Abbau von biologischen Substanzen. | |
ATE253037T1 (de) | Verfahren zur racematspaltung von tramadol | |
EE200200279A (et) | Kõdundamise meetod | |
ATE333903T1 (de) | Verfahren zum auffinden von verbindungen zur vorbeugung von infektion oder pathogenizität | |
ATE247349T1 (de) | Verfahren zum etablieren eines gemeinsamen kryptografischen schüssels für n teilnehmer | |
SE9501808D0 (sv) | New process | |
DE69920708D1 (de) | Verfahren zur herstellung von 1,4-bis[[2-(dimethylamino)ethyl amino]-5,8-dihydroxyanthracene-9,10-dion | |
ATE213782T1 (de) | Verfahren zur biotransformation von colchicinoid- verbindungen in die entsprechenden 3- glycosylderivate | |
ATE225859T1 (de) | Nachweis von antibiotikumresistenzen in mikroorganismen | |
DE60003807D1 (de) | Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung | |
DE59703115D1 (de) | Verfahren zum beschichten von dauerwürsten und hartkäsen | |
DE69011525D1 (de) | Verfahren zur bekämpfung von mikroorganismen. | |
DE69512378D1 (de) | Verfahren zur entfernung von unerwünschten farben aus salzsäure | |
DE69112236D1 (de) | Verfahren zur mikrobiologischen Herstellung von Ironen. | |
DE59814284D1 (de) | Nucleinsäure-sequenzen und verfahren zum nachweis | |
DE69019631D1 (de) | Verfahren zum Schützen und Konservieren von Mikroorganismen, insbesondere von Bakterien. | |
DE69908169D1 (de) | Verfahren zum herstellen von alpha-arylalkansäuren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1129212 Country of ref document: EP |